Page last updated: 2024-12-08
n-acetylneuraminyl-(2-6)-galactose
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
N-acetylneuraminyl-(2-6)-galactose: structure given in first source; RN given refers to D-Gal [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 169679 |
MeSH ID | M0176130 |
Synonyms (7)
Synonym |
---|
alpha-neu5ac-(2-6)-gal |
(2r,4s,5r,6r)-5-acetamido-4-hydroxy-2-[(2r,3s,4s,5r)-2,3,4,5-tetrahydroxy-6-oxohexoxy]-6-[(1r,2r)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid |
d-galactose, 6-o-(n-acetyl-alpha-neuraminosyl)- |
n-acetylneuraminyl-(2-6)-galactose |
W-202445 |
DTXSID10956701 |
6-sialylgalactose |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.89
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.89) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |